Abstract
The renin-angiotensin system (RAS) is activated in heart failure (HF) as a compensatory mechanism, being related to cardiac remodeling and poor prognosis. Although RAS inhibitors are used as first-line drugs for HF, plasma renin activity (PRA) is upregulated by RAS inhibitors via a negative feedback mechanism. The clinical significance of PRA during RAS inhibitor therapy is poorly understood in acute decompensated HF (ADHF). Therefore we examined the impact of PRA in HF patients already receiving RAS inhibitors. Of 611 consecutive patients with ADHF and emergency admission to hospital, we studied the impact of PRA on the prognosis of ADHF in 293 patients already receiving RAS inhibitors before admission. The patients were divided into 2 groups according to median PRA (≥ vs. <3.4 ng·ml(-1)·h(-1)). During a mean follow-up of 29.0 months, there were 124 deaths from all causes. Kaplan-Meier analysis showed that all-cause and cardiovascular mortality were significantly higher in patients with high PRA than low PRA (log-rank P=0.0002 and P<0.0001, respectively). Log PRA was an independent predictor of all-cause and cardiovascular death (HR, 1.194; 95% CI: 1.378-2.678, P<0.0001; and HR, 2.559; 95% CI: 1.610-4.144, P<0.0001, respective...Continue Reading
References
Sep 1, 1973·The American Journal of Medicine·H R BrunnerJ H Laragh
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
May 10, 1995·JAMA : the Journal of the American Medical Association·R Garg, S Yusuf
Sep 1, 1994·Journal of the American College of Cardiology·J L RouleauF Sestier
Oct 1, 1993·Journal of the American College of Cardiology·K K HoD Levy
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
Sep 2, 1999·The New England Journal of Medicine·B PittJ Wittes
Jun 2, 2001·The New England Journal of Medicine·M PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival Study Group
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Sep 19, 2003·Lancet·Marc A PfefferUNKNOWN CHARM Investigators and Committees
Feb 27, 2004·European Heart Journal·Roberto LatiniUNKNOWN Val-HeFT Investigators
Jun 2, 2005·Circulation·Douglas L Mann, Michael R Bristow
Dec 13, 2005·International Journal of Cardiology·R M A van de WalA A Voors
Mar 9, 2010·European Heart Journal·Peter S PangMihai Gheorghiade
Jun 3, 2010·JAMA : the Journal of the American Medical Association·Héctor BuenoHarlan M Krumholz
Jun 24, 2010·Circulation Research·Kenichiro KinouchiHiroshi Itoh
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
May 7, 2011·The American Journal of Cardiology·Giuseppe VergaroClaudio Passino
Jun 23, 2011·Heart Failure Reviews·Nicolas F SchrotenRudolf A de Boer
May 23, 2012·European Heart Journal·John J V McMurrayUNKNOWN ESC Committee for Practice Guidelines
Oct 9, 2012·Circulation·Jennifer K RogersBertram Pitt
Mar 19, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoki SatoUNKNOWN TEND Investigators
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Jun 14, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN JCS Joint Working Group
Jul 13, 2013·Current Pharmaceutical Design·Takashi Ando, Atsuhiro Ichihara
Aug 28, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomoya UedaYoshihiko Saito
Citations
Aug 1, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomoya UedaYoshihiko Saito
Mar 27, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Yukihito Sato
Mar 31, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Tetsuro YokokawaToshihisa Anzai
May 20, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuki KannoYasuchika Takeishi
Dec 3, 2016·Internal Medicine·Hyuma DaidojiToshikazu Goto
Mar 8, 2018·Heart Failure Reviews·Michele CorrealeUNKNOWN Master Program Students on Drug Development for Heart Failure
Nov 17, 2017·European Journal of Heart Failure·Muthiah VaduganathanMihai Gheorghiade
May 20, 2017·Journal of the American Heart Association·Yasuki NakadaYoshihiko Saito
Apr 26, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Takahisa KondoToyoaki Murohara
Jul 22, 2019·ESC Heart Failure·Tomoya UedaYoshihiko Saito
Dec 26, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Satomi IshiharaYoshihiko Saito
Mar 14, 2020·ESC Heart Failure·Masatake KobayashiJoão Pedro Ferreira
May 15, 2020·Journal of the American Heart Association·Maki NogiYoshihiko Saito
Oct 28, 2019·European Journal of Heart Failure·Rayan Jo RachwanPeter S Pang
Jan 10, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Yasuki NakadaYoshihiko Saito
Apr 23, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Daisuke KamonYoshihiko Saito
Nov 4, 2020·Journal of Korean Medical Science·Bo Eun ParkShung Chull Chae
Jan 29, 2021·Scientific Reports·Tomoya UedaYoshihiko Saito
Jul 13, 2021·Circulation Reports·Kaeko HiraiYoshihiko Saito
Jul 22, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masato NaritaHirofumi Tomita